{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:21:45Z","timestamp":1771489305508,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011744","name":"National University Health System","doi-asserted-by":"crossref","award":["NUHSRO\/2011\/005\/STB\/B2B-01"],"award-info":[{"award-number":["NUHSRO\/2011\/005\/STB\/B2B-01"]}],"id":[{"id":"10.13039\/501100011744","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CBRG\/0090\/2015"],"award-info":[{"award-number":["NMRC\/CBRG\/0090\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12017-018-8480-3","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T12:43:08Z","timestamp":1518698588000},"page":"124-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Differential Binding of Human ApoE Isoforms to Insulin Receptor is Associated with Aberrant Insulin Signaling in AD Brain Samples"],"prefix":"10.1007","volume":"20","author":[{"given":"Elizabeth S.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuck Wah","family":"Soong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon-Seng","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"8480_CR1","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., et al. (2009). Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. Journal of Neuroscience, 29, 6771\u20136779.","journal-title":"Journal of Neuroscience"},{"key":"8480_CR2","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences USA, 96, 15233\u201315238.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"8480_CR3","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1097\/00001756-199810050-00031","volume":"9","author":"U Beffert","year":"1998","unstructured":"Beffert, U., & Poirier, J. (1998). ApoE associated with lipid has a reduced capacity to inhibit beta-amyloid fibril formation. NeuroReport, 9, 3321\u20133323.","journal-title":"NeuroReport"},{"key":"8480_CR4","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1073\/pnas.1018381108","volume":"108","author":"N Bien-Ly","year":"2011","unstructured":"Bien-Ly, N., Andrews-Zwilling, Y., Xu, Q., Bernardo, A., Wang, C., & Huang, Y. (2011). C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice. Proceedings of the National Academy of Sciences USA, 108, 4236\u20134241.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"8480_CR5","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","volume":"32","author":"N Bien-Ly","year":"2012","unstructured":"Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y., & Huang, Y. (2012). Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice. Journal of Neuroscience, 32, 4803\u20134811.","journal-title":"Journal of Neuroscience"},{"key":"8480_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J. C., Decker, H., et al. (2012). An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2014associated Abeta oligomers. The Journal of Clinical Investigation, 122, 1339\u20131353.","journal-title":"The Journal of Clinical Investigation"},{"key":"8480_CR7","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.1038\/srep13842","volume":"5","author":"ES Chan","year":"2015","unstructured":"Chan, E. S., Chan, C., Cole, G. M., & Wong, B. S. (2015). Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice. Scientific Reports, 5, 13842.","journal-title":"Scientific Reports"},{"key":"8480_CR8","doi-asserted-by":"publisher","first-page":"26119","DOI":"10.1038\/srep26119","volume":"6","author":"ES Chan","year":"2016","unstructured":"Chan, E. S., Shetty, M. S., Sajikumar, S., Chen, C., Soong, T. W., & Wong, B.-S. (2016). ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing A\u03b2 impairment of insulin signaling in an Alzheimer\u2019s disease mouse model. Scientific Reports, 6, 26119.","journal-title":"Scientific Reports"},{"key":"8480_CR9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-2012-111880","volume":"29","author":"LM Chua","year":"2012","unstructured":"Chua, L. M., Lim, M. L., Chong, P. R., Hu, Z. P., Cheung, N. S., & Wong, B. S. (2012). Impaired neuronal insulin signaling precedes A beta(42) accumulation in female A beta PPsw\/PS1 Delta E9 Mice. Journal of Alzheimer\u2019s Disease, 29, 783\u2013791.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"8480_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exger.2006.08.009","volume":"42","author":"GM Cole","year":"2007","unstructured":"Cole, G. M., & Frautschy, S. A. (2007). The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer\u2019s disease. Experimental Gerontology, 42, 10\u201321.","journal-title":"Experimental Gerontology"},{"key":"8480_CR11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science, 261, 921\u2013923.","journal-title":"Science"},{"key":"8480_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","volume":"10","author":"SC Correia","year":"2011","unstructured":"Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011). Insulin-resistant brain state: The culprit in sporadic Alzheimer\u2019s disease? Ageing Research Reviews, 10, 264\u2013273.","journal-title":"Ageing Research Reviews"},{"key":"8480_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","volume":"28","author":"S Craft","year":"2003","unstructured":"Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M., Purganan, K., et al. (2003). Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer\u2019s disease: Interactions with apolipoprotein E genotype. Psychoneuroendocrinology, 28, 809\u2013822.","journal-title":"Psychoneuroendocrinology"},{"key":"8480_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft, S., Baker, L. D., Montine, T. J., Minoshima, S., Watson, G. S., Claxton, A., et al. (2012). Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Archives of Neurology, 69, 29\u201338.","journal-title":"Archives of Neurology"},{"key":"8480_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","volume":"3","author":"S Craft","year":"2004","unstructured":"Craft, S., & Watson, G. S. (2004). Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology, 3, 169\u2013178.","journal-title":"Lancet Neurology"},{"key":"8480_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y., Karlo, J. C., Zinn, A. E., et al. (2012). ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science, 335, 1503\u20131506.","journal-title":"Science"},{"key":"8480_CR17","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","volume":"106","author":"FG Felice De","year":"2009","unstructured":"De Felice, F. G., Vieira, M. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., et al. (2009). Protection of synapses against Alzheimer\u2019s-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers. Proceedings of the National Academy of Sciences USA, 106, 1971\u20131976.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"8480_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5483\/BMBRep.2009.42.8.475","volume":"42","author":"SM Monte de la","year":"2009","unstructured":"de la Monte, S. M. (2009). Insulin resistance and Alzheimer\u2019s disease. BMB Reports, 42, 475\u2013481.","journal-title":"BMB Reports"},{"key":"8480_CR19","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1523\/JNEUROSCI.1074-10.2010","volume":"30","author":"H Decker","year":"2010","unstructured":"Decker, H., Lo, K. Y., Unger, S. M., Ferreira, S. T., & Silverman, M. A. (2010). Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. Journal of Neuroscience, 30, 9166\u20139171.","journal-title":"Journal of Neuroscience"},{"key":"8480_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Frolich","year":"1998","unstructured":"Frolich, L., Blum-Degen, D., Bernstein, H. G., Engelsberger, S., Humrich, J., Laufer, S., et al. (1998). Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease. Journal of Neural Transmission, 105, 423\u2013438.","journal-title":"Journal of Neural Transmission"},{"key":"8480_CR21","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1021\/bi5008172","volume":"53","author":"K Garai","year":"2014","unstructured":"Garai, K., Verghese, P. B., Baban, B., Holtzman, D. M., & Frieden, C. (2014). The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation. Biochemistry, 53, 6323\u20136331.","journal-title":"Biochemistry"},{"key":"8480_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","volume":"87","author":"P Gual","year":"2005","unstructured":"Gual, P., Le Marchand-Brustel, Y., & Tanti, J. F. (2005). Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie, 87, 99\u2013109.","journal-title":"Biochimie"},{"key":"8480_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0166-2236(02)00040-1","volume":"26","author":"GE Hardingham","year":"2003","unstructured":"Hardingham, G. E., & Bading, H. (2003). The Yin and Yang of NMDA receptor signalling. Trends in Neurosciences, 26, 81\u201389.","journal-title":"Trends in Neurosciences"},{"key":"8480_CR24","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1126\/science.287.5461.2262","volume":"287","author":"Y Hayashi","year":"2000","unstructured":"Hayashi, Y., Shi, S. H., Esteban, J. A., Piccini, A., Poncer, J. C., & Malinow, R. (2000). Driving AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1 and PDZ domain interaction. Science, 287, 2262\u20132267.","journal-title":"Science"},{"key":"8480_CR25","doi-asserted-by":"publisher","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","volume":"4","author":"BA Hemmings","year":"2012","unstructured":"Hemmings, B. A., & Restuccia, D. F. (2012). PI3K-PKB\/Akt pathway. Cold Spring Harbor Perspectives in Biology, 4, a011189.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"8480_CR26","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jalz.2013.12.006","volume":"10","author":"C Holscher","year":"2014","unstructured":"Holscher, C. (2014). First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association, 10, S33\u2013S37.","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"key":"8480_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s007020200082","volume":"109","author":"S Hoyer","year":"2002","unstructured":"Hoyer, S. (2002). The aging brain. Changes in the neuronal insulin\/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. Journal Of Neural Transmission, 109, 991\u20131002.","journal-title":"Journal Of Neural Transmission"},{"key":"8480_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang, Y., & Mucke, L. (2012). Alzheimer mechanisms and therapeutic strategies. Cell, 148, 1204\u20131222.","journal-title":"Cell"},{"issue":"1013\u20131023","key":"8480_CR29","first-page":"e1014","volume":"96","author":"T-PV Huynh","year":"2017","unstructured":"Huynh, T.-P. V., Liao, F., Francis, C. M., Robinson, G. O., Serrano, J. R., Jiang, H., et al. (2017). Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron, 96(1013\u20131023), e1014.","journal-title":"Neuron"},{"key":"8480_CR30","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor, P. N., Buniel, M. C., Furlow, P. W., Clemente, A. S., Velasco, P. T., Wood, M., et al. (2007). Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. Journal of Neuroscience, 27, 796\u2013807.","journal-title":"Journal of Neuroscience"},{"key":"8480_CR31","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994). Isoform-specific binding of apolipoprotein E to beta-amyloid. Journal of Biological Chemistry, 269, 23403\u201323406.","journal-title":"Journal of Biological Chemistry"},{"key":"8480_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neurobiolaging.2007.06.014","volume":"30","author":"CC Lee","year":"2009","unstructured":"Lee, C. C., Kuo, Y. M., Huang, C. C., & Hsu, K. S. (2009). Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation. Neurobiology of Aging, 30, 377\u2013387.","journal-title":"Neurobiology of Aging"},{"key":"8480_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2011.06.170","volume":"411","author":"M Li","year":"2011","unstructured":"Li, M., Zhang, D. Q., Wang, X. Z., & Xu, T. J. (2011). NR2B-containing NMDA receptors promote neural progenitor cell proliferation through CaMKIV\/CREB pathway. Biochemical and Biophysical Research Communications, 411, 667\u2013672.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1024\u20131032","key":"8480_CR34","first-page":"e1023","volume":"96","author":"C-C Liu","year":"2017","unstructured":"Liu, C.-C., Zhao, N., Fu, Y., Wang, N., Linares, C., Tsai, C.-W., et al. (2017). ApoE4 accelerates early seeding of amyloid pathology. Neuron, 96(1024\u20131032), e1023.","journal-title":"Neuron"},{"key":"8480_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.brainres.2010.09.035","volume":"1361","author":"Z Liu","year":"2010","unstructured":"Liu, Z., Zhao, W., Xu, T., Pei, D., & Peng, Y. (2010). Alterations of NMDA receptor subunits NR1, NR2A and NR2B mRNA expression and their relationship to apoptosis following transient forebrain ischemia. Brain Research, 1361, 133\u2013139.","journal-title":"Brain Research"},{"key":"8480_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley, R. W., & Huang, Y. (2012). Apolipoprotein e sets the stage: Response to injury triggers neuropathology. Neuron, 76, 871\u2013885.","journal-title":"Neuron"},{"key":"8480_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.neuro.25.112701.142758","volume":"25","author":"R Malinow","year":"2002","unstructured":"Malinow, R., & Malenka, R. C. (2002). AMPA receptor trafficking and synaptic plasticity. Annual Review of Neuroscience, 25, 103\u2013126.","journal-title":"Annual Review of Neuroscience"},{"key":"8480_CR38","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning, B. D., & Cantley, L. C. (2007). AKT\/PKB signaling: Navigating downstream. Cell, 129, 1261\u20131274.","journal-title":"Cell"},{"key":"8480_CR39","doi-asserted-by":"crossref","first-page":"28783","DOI":"10.1016\/S0021-9258(19)61974-5","volume":"269","author":"MG Myers Jr","year":"1994","unstructured":"Myers, M. G., Jr., Grammer, T. C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., et al. (1994). Insulin receptor substrate-1 mediates phosphatidylinositol 3\u2032-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. Journal of Biological Chemistry, 269, 28783\u201328789.","journal-title":"Journal of Biological Chemistry"},{"key":"8480_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12017-012-8184-z","volume":"14","author":"R Nistico","year":"2012","unstructured":"Nistico, R., Cavallucci, V., Piccinin, S., Macri, S., Pignatelli, M., Mehdawy, B., et al. (2012). Insulin receptor beta-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromolecular Medicine, 14, 262\u2013269.","journal-title":"Neuromolecular Medicine"},{"key":"8480_CR41","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/srep03754","volume":"4","author":"QR Ong","year":"2014","unstructured":"Ong, Q. R., Chan, E. S., Lim, M. L., Cole, G. M., & Wong, B. S. (2014). Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci Rep, 4, 3754.","journal-title":"Sci Rep"},{"key":"8480_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop, J. J., & Mucke, L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: From synapses toward neural networks. Nature Neuroscience, 13, 812\u2013818.","journal-title":"Nature Neuroscience"},{"key":"8480_CR43","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","volume":"25","author":"F Roselli","year":"2005","unstructured":"Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., et al. (2005). Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. Journal of Neuroscience, 25, 11061\u201311070.","journal-title":"Journal of Neuroscience"},{"key":"8480_CR44","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., et al. (1994). Apolipoprotein E associates with beta amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. The Journal of Clinical Investigation, 94, 860\u2013869.","journal-title":"The Journal of Clinical Investigation"},{"key":"8480_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/cshperspect.a004457","volume":"3","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe, D. J. (2011). Alzheimer\u2019s disease. Cold Spring Harbor Perspectives in Biology, 3, 7.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"8480_CR46","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","volume":"288","author":"LM Tai","year":"2013","unstructured":"Tai, L. M., Bilousova, T., Jungbauer, L., Roeske, S. K., Youmans, K. L., Yu, C., et al. (2013). Levels of soluble apolipoprotein E\/amyloid-beta (Abeta) complex are reduced and oligomeric Abeta increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. Journal of Biological Chemistry, 288, 5914\u20135926.","journal-title":"Journal of Biological Chemistry"},{"key":"8480_CR47","doi-asserted-by":"publisher","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","volume":"289","author":"LM Tai","year":"2014","unstructured":"Tai, L. M., Koster, K. P., Luo, J., Lee, S. H., Wang, Y. T., Collins, N. C., et al. (2014). Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. Journal of Biological Chemistry, 289, 30538\u201330555.","journal-title":"Journal of Biological Chemistry"},{"key":"8480_CR48","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K., Wang, H. Y., Kazi, H., Han, L. Y., Bakshi, K. P., Stucky, A., et al. (2012). Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. Journal of Clinical Investigation, 122, 1316\u20131338.","journal-title":"Journal of Clinical Investigation"},{"key":"8480_CR49","doi-asserted-by":"publisher","first-page":"33305","DOI":"10.1074\/jbc.M610390200","volume":"282","author":"M Townsend","year":"2007","unstructured":"Townsend, M., Mehta, T., & Selkoe, D. J. (2007). Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. Journal of Biological Chemistry, 282, 33305\u201333312.","journal-title":"Journal of Biological Chemistry"},{"key":"8480_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/psc.573","volume":"10","author":"Y Verdier","year":"2004","unstructured":"Verdier, Y., Zarandi, M., & Penke, B. (2004). Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer\u2019s disease. Journal of Peptide Science, 10, 229\u2013248.","journal-title":"Journal of Peptide Science"},{"key":"8480_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011). Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurology, 10, 241\u2013252.","journal-title":"Lancet Neurology"},{"key":"8480_CR52","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","volume":"22","author":"L Xie","year":"2002","unstructured":"Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., Van Bronswijk, W., & Martins, R. (2002). Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor. The Journal of Neuroscience, 22, RC221.","journal-title":"The Journal of Neuroscience"},{"key":"8480_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","volume":"177","author":"WQ Zhao","year":"2001","unstructured":"Zhao, W. Q., & Alkon, D. L. (2001). Role of insulin and insulin receptor in learning and memory. Molecular and Cellular Endocrinology, 177, 125\u2013134.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"8480_CR54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","volume":"22","author":"WQ Zhao","year":"2008","unstructured":"Zhao, W. Q., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., et al. (2008). Amyloid beta oligomers induce impairment of neuronal insulin receptors. The FASEB Journal, 22, 246\u2013260.","journal-title":"The FASEB Journal"},{"issue":"115\u2013129","key":"8480_CR55","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Martens, Y. A., Linares, C., Knight, J. A., et al. (2017). Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron, 96(115\u2013129), e115.","journal-title":"Neuron"},{"key":"8480_CR56","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","volume":"24","author":"L Zhao","year":"2004","unstructured":"Zhao, L., Teter, B., Morihara, T., Lim, G. P., Ambegaokar, S. S., Ubeda, O. J., et al. (2004). Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer\u2019s disease intervention. Journal of Neuroscience, 24, 11120\u201311126.","journal-title":"Journal of Neuroscience"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-018-8480-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T11:20:08Z","timestamp":1660476008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-018-8480-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["8480"],"URL":"https:\/\/doi.org\/10.1007\/s12017-018-8480-3","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"1 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The human postmortem frontal cortex samples were provided by the Alzheimer Disease Research Center (ADRC) at the University of California San Diego (UCSD). Patient consent had been administered at UCSD ADRC. The samples were provided in a coded fashion. Research has been conducted according to the principles expressed in the Declaration of Helsinki. Analysis of the de-identified samples was performed with research approval by the National University of Singapore (NUS) Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}